These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 19169210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
    Meissner K, Löning T, Rehpenning W.
    Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
    [Abstract] [Full Text] [Related]

  • 8. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL.
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [Abstract] [Full Text] [Related]

  • 9. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
    Chong BF, Wilson AJ, Gibson HM, Hafner MS, Luo Y, Hedgcock CJ, Wong HK.
    Clin Cancer Res; 2008 Feb 01; 14(3):646-53. PubMed ID: 18245523
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM, Cerroni L.
    Am J Dermatopathol; 2015 Feb 01; 37(2):115-21. PubMed ID: 25406852
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep 01; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

  • 19. Immunobiology and treatment of cutaneous T-cell lymphoma.
    Goel RR, Rook AH.
    Expert Rev Clin Immunol; 2024 Aug 01; 20(8):985-996. PubMed ID: 38450476
    [Abstract] [Full Text] [Related]

  • 20. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
    Wong HK, Mishra A, Hake T, Porcu P.
    Br J Haematol; 2011 Oct 01; 155(2):150-66. PubMed ID: 21883142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.